New Delhi, Febraury 14, 2019: Eisai Co., Ltd. announced today that it has submitted an application to the European Medicines Agency…
As Monotherapy for Partial-Onset Seizures, Pediatric Indication for Partial-Onset Seizures, as Well as New Formulation Tokyo, February 03, 2019: Eisai Co., Ltd.…
As Monotherapy for Partial-Onset Seizures, Pediatric Indication for Partial-Onset Seizures, as Well as New Formulation Tokyo, January 31, 2019: Eisai…